BioCentury
ARTICLE | Company News

Management tracks

February 26, 2016 1:51 AM UTC

Gene therapy company bluebird bio Inc. (NASDAQ:BLUE) said CFO Jim DeTore resigned, effective March 18. bluebird COO Jeffrey Walsh will become CFO and chief strategy officer, effective March 1. Walsh will step down as COO on Feb. 29.

Fertility company OvaScience Inc. (NASDAQ:OVAS) hired Paul Chapman as COO. He was regional president of North America at ArjoHuntleigh AB (Malmo, Sweden). ...